account_balance
Investment manager · 13F filer · SEC CIK 310158
Merck & Co., Inc.
Reported value$526Mas of Jun 30, 2026
Positions13 3 new, 4 sold out
Top 10 weight100%PSNL alone is 36%
FiledAug 738 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
PSNL
Personalis INC
35.8%
MRNA
Moderna INC
30.7%
KYMR
Kymera Therapeutics INC
16.8%
AKTS
Aktis Oncology INC
5.8%
EIKN
Eikon Therapeutics INC
4.1%
TRDA
Entrada Therapeutics INC
2.4%New
STRO
Sutro Biopharma INC
1.7%New
ALEC
1.4%
EVAX
0.7%
VRDN
0.3%
3 others
0.2%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed